Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07150923 · ClinicalTrials.gov registry record · NA

Supraglottic Airway for Resuscitation Trial

A NA study of Infant, Newborn and Implementation Research, sponsored by Children's Hospital of Philadelphia.

Recruiting
Registry status
NA
Development phase
36,503
Enrollment target
20
Study locations

NCT07150923 is a NA study of Infant, Newborn and Implementation Research that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 36,503 participants, below the 225,671-participant average among 14 other Infant, Newborn trials with a reported enrollment target (84% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07150923, a NA study of Infant, Newborn and Implementation Research, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.

RECRUITING
Registry status
NA
Development phase
36,503 participants
Enrollment target
20
Study locations

Study Summary

This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.

Interventions

  • OTHER Enhanced Standard of Care ("Enhanced")
  • OTHER Enhanced Standard of Care ("Enhanced-Plus")

Study Locations (20)

California

  • Sharp Chula Vista Medical Center - Chula Vista
  • Sharp Grossmont Hospital - La Mesa
  • Cedars-Sinai Medical Center - Los Angeles
  • Rady Children's NICU at Rancho Springs Medical Center - Murrieta
  • Lucile Packard Children's Hospital - Palo Alto
  • Jacobs Medical Center at University of California San Diego Health - San Diego
  • Sharp Mary Birch Hospital for Women & Newborns - San Diego

New York

  • South Shore University Hospital - Bay Shore
  • Lenox Hill Hospital - New York
  • Cohen Children's Medical Center - Queens

Maine

  • MaineHealth Mid Coast Hospital - Brunswick
  • MaineHealth Maine Medical Center - Portland

Alabama

  • University of Alabama at Birmingham - Birmingham

Arkansas

  • University of Arkansas for Medical Sciences - Little Rock

Delaware

  • ChristianaCare - Newark

Illinois

  • St. John's Children's Hospital - Springfield

Indiana

  • Riley Hospital for Children - Indianapolis

Trial Details

FieldValue
Enrollment Target 36,503 participants
Start Date 2026-01-01
Est. Completion 2029-09
Phase NA

Sponsor

Children's Hospital of Philadelphia

431 total trials

What the Registry Record Tells You About NCT07150923

The ClinicalTrials.gov registry entry for NCT07150923 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 36,503 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 225,671-participant average among 14 other Infant, Newborn trials with a reported enrollment target (84% lower). The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.

The record links to 7 conditions, with Infant, Newborn appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Standard of Care ("Enhanced") is the first listed.

NCT07150923 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, New York, Maine.

Frequently Asked Questions

What is clinical trial NCT07150923 about?

NCT07150923 is a clinical study titled "Supraglottic Airway for Resuscitation Trial". This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.

What is the current status of trial NCT07150923?

This trial is currently recruiting. It is a NA study. The enrollment target is 36,503 participants. The study started on 2026-01-01. Estimated completion is 2029-09.

What conditions does trial NCT07150923 study?

This clinical trial studies the following conditions: Infant, Newborn, Implementation Research, Neonatal Resuscitation, Supraglottic Airway, Delivery Room Resuscitation.

What interventions are being tested in trial NCT07150923?

The interventions under investigation include: Enhanced Standard of Care ("Enhanced") (OTHER), Enhanced Standard of Care ("Enhanced-Plus") (OTHER).

Who is sponsoring clinical trial NCT07150923?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07150923 being conducted?

This trial has 20 study locations across Alabama, Arkansas, California, Delaware, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant, Newborn

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.